Table 2.
Control Group (n = 17) |
Experimental Group (n = 18) |
p | |
---|---|---|---|
Age (year) | 62.4 ± 13.3 | 60.2 ± 11.7 | 0.444 |
Gender (male/female) | 9/8 | 10/8 | 0.122 |
Height (cm) | 164.1 ± 6.7 | 166.1 ± 6.7 | 0.352 |
Weight (kg) | 64.2 ± 10.2 | 74.6 ± 17.8 | 0.501 |
Stroke onset time (weeks) | 6.9 ± 2.2 | 7.0 ± 2.7 | 0.695 |
Affected side (left/right) | 7 /10 | 6/12 | 0.631 |
Stroke type (infarction/hemorrhage) | 6/11 | 6/12 | 0.833 |
Stroke location (number of participants) | |||
Corona radiate | 3 | 2 | |
Putamen | 5 | 7 | |
Pons | 2 | 2 | |
Thalamus | 1 | 1 | |
Basal ganglion | 4 | 2 | |
Frontal–temporal lobe | 1 | 0 | |
Parieto-occipital lobe | 0 | 1 | |
Corona radiate, basal ganglion, putamen | 1 | 2 | |
Basal ganglion, thalamus | 1 | 0 | |
Modified Ashworth scale (mean/median/mode) | |||
Hip adductor | 0.1/0/0 | 0.2/0/0 | 0.581 |
Hip flexor | 0.0/0/0 | 0.1/0/0 | 0.157 |
Hip extensor | 0.1/0/0 | 0.2/0/0 | 0.316 |
Knee extensor | 0.1/0/0 | 0.3/0/0 | 0.615 |
Ankle dorsiflexor | 0.0/0/0 | 0.4/0/0 | 0.212 |
Ankle plantarflexor | 0.3/0/0 | 0.5/0/0 | 0.549 |